GNMSF:OTCMKTS
Genmab
$367.00
0.00%
(0.00) 1D
Okt 9, 10:28:36 AM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa GNMSF...
Mkt. cap
23.21B
Avg. na dami
1.37K
Dami
0.00
Mataas nang 52-wk
$396.97
Mababa nang 52-wk
$232.50
Beta
0.73
Mga natitirang share
62.41M
Bilang ng mga empleyado
3K
Mkt. cap
23.21B
Avg. na dami
1.37K
Dami
0.00
Mataas nang 52-wk
$396.97
Mababa nang 52-wk
$232.50
Beta
0.73
Mga natitirang share
62.41M
Bilang ng mga empleyado
3K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
TipRanks
·
1 araw ang nakalipas
Genmab Reports USD 4.2 Billion in Q3 2026 DARZALEX Net Sales
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
Tungkol sa Genmab
CEOJan G. J. van de Winkel
Mga Empleyado3.12K
ItinatagHun 11, 1998
Headquarters-
Sektor-
Websitegenmab.com